Sponsors
- Limbus Medical TechnologiesAccelerate/Gold
- NonacusAccelerate/Gold
- QiagenAccelerate/Gold
- GenomizeGrow/Silver
- enGenomeBuild/Bronze
- Variant prioritization by pathogenicity and clinical significance
- Classification accuracy up to 98%
- Nuclear and mitochondrial DNA analysis
- VUS reduction up to 60%
- GDPR compliant, CE IVD and ISO 13485 certified
- EpivalueInform/Copper
- ready-made solutions for lung cancer profiling, neonatal screening, HLA typing and more;
- components for creating cross-platform NGS libraries;
- proprietary pipelines providing SNV, MNV, INDEL and RNA fusion detection with fully automated samples’ QC control, including sex determination and contamination detection;
- software solutions intended for variants annotation based on AMP and ACMG criteria with the capability of custom annotations;
- OEM production of commercial NGS assays according to your technical specifications.
- X-omicsInform/Copper
Accelerate/Gold
The varvis® genomics platform is a cloud-based and standardized software solution for clinical genetics. It supports the entire NGS workflow from raw data processing and genomics data management to variant interpretation and includes clinically validated and automated CNV and SNV/Indel analysis. varvis® allows you to build your own comprehensive in-house variant database from the entire analysis history, but also leverages the variant data from all users to help solving even complex WES or WGS cases. Our services comprise first-class support, training, automated quality control and validation compliant with relevant international guidelines. varvis® is a registered CE-IVD device and as such specifically designed to aid in the diagnosis of patients.
Contact: info@varvis.com
Website: www.varvis.com
https://www.limbus-medtec.com/Nonacus is a leading provider of genetic testing products headquartered in Birmingham, UK. Collaborating closely with scientists and clinicians, the company is developing a comprehensive precision oncology workflow including support for primary tumor and liquid biopsy analysis with the ultimate goal of creating a world where early cancer diagnosis, detection and management is simple and universally available.
https://nonacus.com/QIAGEN Digital Insights, the bioinformatics business of QIAGEN, is the leading provider of genomic and clinical knowledge, analysis and interpretation tools and services for scientists and clinicians. We have over 25 years of experience in the industry, 90,000 users worldwide, over 100,000 citations in scientific papers, more than 3.5 million profiled patient cases and over 40 billion scientific data points. Discover our portfolio of expertly curated genomic and clinical knowledge solutions as well as bioinformatics software and services for efficient data management, sharing and actionable insights. http://digitalinsights.qiagen.com
https://digitalinsights.qiagen.com/Grow/Silver
Genomize with 10+ years of experience in unlocking the power of genomics, joins isv24 to showcase their SEQ platform, a CE-IVD-certified and GDPR-complaint clinical NGS data processing and variant interpretation platform with AI-guided variant prioritization, user-friendly UI, real-time frequency database, CNV, multi-sample analyses, structural variants, integrated reporting system and more. SEQ has empowered 350+ centers in 25+ countries, positively impacting the lives of over 250,000 patients. Visit Genomize’s talk to explore how clinical insights are just a few clicks away.
https://genomize.comBuild/Bronze
enGenome offers innovative software and bioinformatics services for interpreting sequencing data.
The flagship product, eVai, is a cloud-based solution that leverages Artificial Intelligence to accurately prioritize genetic variants.
Recognized as the best performing predictor at the NIH-funded CAGI6 challenge, increasing diagnostic yield by 12.5%, eVai performs:
Come meet us!
https://www.engenome.com/Inform/Copper
Epivalue is an expert team passionate about creating state-of-the-art genetic analysis solutions for clinical and research needs. We develop and produce complete solutions based on the NGS technology empowered by comprehensive and user-friendly GeneValue® software for secondary analysis and some fractions of tertiary annotation. By seamlessly combining the finest panel design, high-grade reagent kits producing and know-how software, we generate a harmonised portfolio consisting of:
The Netherlands X-omics Initiative (X-omics, pronounce as CROSS-omics) is a National Roadmap Large-Scale Research Infrastructure, partially funded by NWO with a total budget of 40 million euro.
X-omics aims to establish a X-omics research infrastructure across the Netherlands, by combining technologies in the field of genomics, proteomics, metabolomics and data analysis, integration & stewardship.
With this infrastructure biomedical problems can be solved using an integrated approach (analysis of samples using the available omics technologies of the infrastructure).
https://www.x-omics.nl/